Charlie Hospital Semarang Tbk. vs Surya Biru Murni Acetylene Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Surya Biru Murni Acetylene Tbk. trades at Rp110 (market cap 100.43B, 89.1K 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 7.4× Surya Biru Murni Acetylene Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 89.1K). Which is the better fit depends on your goals.
| RSCH | SBMA | |
|---|---|---|
Market Cap | 742B | 100.43B |
Volume | 29.45M | 89.1K |
Lot | 294.49K | 891 |
Turnover | 8.14B | 9.59M |
Average Price | 276.35 | 107.62 |
Value | 8.14B | 9.59M |
Indicative Equilibrium Price | 270 | 110 |
Indicative Equilibrium Volume | 103 | 2 |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Surya Biru Murni Acetylene Tbk (the Company) was established in Balikpapan based on Notarial Deed No. 57 of Mohamad Rasjid Umar, S.H., dated October 25, 1980. The Company started its commercial operations in 1982.
Read more on SBMA →